Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?

Stocks Yahoo Finance By Yahoo Finance 27 Jul 2026 20:20 1 min read
Edwards Lifesciences (EW)’s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Analyst targets on Edwards Lifesciences

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $EW yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Edwards Lifesciences →
Read the full story on Yahoo Finance → Opens the original article on finance.yahoo.com

Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.